Letter to the Editor
BRAF V600E is not a consistent feature of myopericytoma
Jeffrey K. Mito MD, PhD,
Jeffrey K. Mito MD, PhD
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Search for more papers by this author Vickie Y. Jo MD,
Vickie Y. Jo MD
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Search for more papers by this author
Jeffrey K. Mito MD, PhD,
Jeffrey K. Mito MD, PhD
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Search for more papers by this author Vickie Y. Jo MD,
Vickie Y. Jo MD
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
Search for more papers by this author
First published: 10 November 2016
No abstract is available for this article.
References
- 1 C Fletcher, J Bridge, P Hogendoorn (eds). WHO classification of tumours of soft tissue and bone. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2013.
- 2Mentzel T, Dei Tos AP, Sapi Z, et al. Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 2006; 30: 104.
- 3McMenamin ME, Fletcher CD. Malignant myopericytoma: expanding the spectrum of tumours with myopericytic differentiation. Histopathology 2002; 41: 450.
- 4Stenman G, Nadal N, Persson S, et al. Del(6)(q12q15) as the sole cytogenetic anomaly in a case of solitary infantile myofibromatosis. Oncol Rep 1999; 6: 1101.
- 5Sirvent N, Perrin C, Lacour JP, et al. Monosomy 9q and trisomy 16q in a case of congenital solitary infantile myofibromatosis. Virchows Arch 2004; 445: 537.
- 6Dahlen A, Fletcher CD, Mertens F, et al. Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol 2004; 164: 1645.
- 7Sadow PM, Priolo C, Nanni S, et al. Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment. J Natl Cancer Inst 2014; 106: dju182.
- 8Ritterhouse LL, Barletta JA. BRAF V600E mutation-specific antibody: a review. Semin Diagn Pathol 2015; 32: 400.
- 9Capper D, Preusser M, Habel A, et al. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol 2011; 122: 11.
